approval
saveSANDIMMUNE (CYCLOSPORINE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 213d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 213d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 213d ago
- approvalCYCLOSPORINE — FDA approvalNov 28, 2025 · 311d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1103d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1103d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1103d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 16, 2022 · 1664d ago
same company · ±60 days · 6
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalJul 8, 2016
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalJun 17, 2016
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalJun 17, 2016
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalJun 16, 2016
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 25, 2016
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 25, 2016
comments(0)
5-min edit window · permanent after that